After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ciudad de México, Mexico, 07020
- UMAE Dr. Victorio de La Fuente Narvaez
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients knee arthrosis
- Required a surgical treatment with Total Knee Arthroplasty
Exclusion Criteria:
- Not accept to be in the study
- Not signed consent form
- Not having blood sample for creatinin meassure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: TKA and Tourniquet
Total knee arthroplasty and use of tourniquet limb cuff at 270 mmHg
|
Total knee arhroplasty
Other Names:
Tourniquet limb cuff and regular anesthesia
|
|
Experimental: Intraarticular lidocain
Total knee arthroplasty with Intaarticular lidocain
|
Total knee arhroplasty
Other Names:
20 ml of 2% lidocain application intraarticular before surgery (intraarticular lidocain)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Creatinin before surgery
Time Frame: Creatinin before surgery
|
Blood Creatinin meassure in mg/dl before surgery
|
Creatinin before surgery
|
|
Creatinin after surgery 1
Time Frame: Creatinin after surgery 1 at 24 hours
|
Blood Creatinin meassure in mg/dl at 24 hours
|
Creatinin after surgery 1 at 24 hours
|
|
Creatinin after surgery 2
Time Frame: Creatinin after surgery 2 at 48 hours
|
Blood Creatinin meassure in mg/dl at 48 hours
|
Creatinin after surgery 2 at 48 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Avelino Colin Vázquez, MD, IMSS
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Kidney Diseases
- Urologic Diseases
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Osteoarthritis, Knee
- Renal Insufficiency
- Acute Kidney Injury
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
Other Study ID Numbers
Other Study ID Numbers
- R-2018-3401-053
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.